| 摘要 |
<p>FIELD: medicine.SUBSTANCE: invention describes a method for typing in vitro an inflammatory rheumatic disease, namely for differentiating rheumatoid arthritis and arthritis related to skin disease, wherein the presence or absence of joint fluid Hdj2 protein at the early stage of the disease, i.e. for a period of time up to two years from the onset of first symptoms of inflammatory rheumatoid arthritis, is determined. What is also described is using Hdj2 protein monoclonal antibodies for the purpose of differential diagnosis in vitro of the inflammatory rheumatic disease.EFFECT: invention enables the early diagnosis of rheumatoid arthritis.5 cl, 4 ex, 3 dwg, 3 tbl</p> |
